Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Gary Mohilner who wrote (2987)	4/6/2000 3:32:00 PM
From: misti30	Read Replies (1) \| Respond to of 5665

Hey guys, when you feel depression setting in, go back and read Mitch's 'current' comments in post #2975. In my simple way I see that he feels there are three areas of importance that are unfolding as we speak. The first is toxicity. "ABSOLUTELY NO EVIDENCE OF TOXICITY WHATSOEVER." (these quotes were all caps in n2health's post). The second is immunity production. "...no evidence of toxicity or immunogenicity. Again, NO TOXICITY. NO IMMUNOGENICITY. So we're pretty pleased with these results." And the third is efficacy. In his web message he has apologized for not saying "hey, it works," but it just isn't time. In the post; "SBH begins this phase 1 very shortly, a multi-dose study, and then we'll go into phase 2 and hopefully that phase 2 will be a pivotal study looking for the CURES in the same, or impact in the same patient population as we are treating in the phase 1 studies." I don't believe they have anything further to say until this phase 2 trial is underway. I really believe he's said all he can; and in this case it's quite a bit. As recently as March 27, before an audience of his peers Mitch was optimistic, effusive actually, about the potential for his product. "I'm here to talk to you because we believe we have an ENABLING technology here." I feel good. Everything's going to be alright.. misti